What the Company Does

Nabla builds and operates an ambient AI assistant for clinicians. The central problem the company addresses is clinician burnout driven by documentation demands. Studies and industry surveys have consistently shown that healthcare providers spend a large portion of their working hours on administrative and note-taking tasks, often extending their work well beyond patient visits into what is commonly called "pajama time" — the hours spent completing charts after normal working hours.

Nabla's technology listens to the natural conversation that occurs between a clinician and a patient during a medical encounter, and it automatically generates structured clinical documentation from that conversation. The system uses speech recognition combined with large language models and natural language processing to transform spoken dialogue into an organized clinical note. This process is designed to happen ambiently, meaning the clinician does not need to interact directly with a device or type during the visit; the technology works in the background while the provider maintains eye contact and attention on the patient.

The company positions itself in the growing category of ambient clinical intelligence and AI medical scribe technology. Rather than requiring a human scribe or manual dictation, Nabla automates the creation of notes, allowing providers to review and finalize documentation quickly.

Core Product: Nabla Copilot

The company's flagship product is Nabla Copilot, an ambient AI assistant built specifically for clinical use. Key aspects of the product include:

Ambient note generation. Nabla Copilot captures the natural conversation during a patient encounter and produces a draft clinical note. The note is generated in a structured format that reflects the standard components of medical documentation, such as history of present illness, assessment, and plan.

Multi-specialty support. The tool is designed to work across a range of medical specialties and care settings, adapting the documentation output to the context of the visit and the needs of different types of providers.

Multilingual capability. Nabla has developed support for multiple languages, which is significant for its operations both in Europe and North America. The system can handle conversations conducted in different languages and produce notes accordingly, which helps serve diverse patient populations and clinician workforces.

Customizable output. Clinicians can tailor how notes are formatted and structured to match their personal preferences, their organization's templates, and specific specialty requirements.

Integration with electronic health records. Nabla Copilot is built to integrate with the electronic health record systems that clinicians already use, allowing generated notes to flow into the systems of record without excessive manual copying and pasting. The company has worked to build integrations that fit into existing clinical workflows.

Additional clinical support features. Beyond note creation, the platform has expanded to include functionality that assists with related tasks such as generating patient instructions, drafting letters and orders, and surfacing relevant information to reduce the cognitive and administrative load on the provider.

How the Technology Works

Nabla's approach combines several layers of technology. First, audio from the clinical encounter is processed through automatic speech recognition to convert spoken words into text. Next, the transcribed conversation is analyzed by language models that are tuned for medical context, which identify clinically relevant information and organize it into the appropriate sections of a note. The output is then presented to the clinician for review, edit, and approval before it becomes part of the patient record.

A distinguishing element of Nabla's philosophy is the emphasis on keeping the clinician in control. The AI is intended to serve as an assistant that produces a draft, not an autonomous system that makes clinical decisions. The human provider remains responsible for reviewing and validating the documentation, which is important both for quality and for regulatory and safety considerations.

Nabla has also invested in the responsible development of its AI, including attention to accuracy, safety, and privacy. Given the sensitive nature of health data, the company operates within the frameworks required for handling protected health information and patient privacy, addressing standards relevant in the jurisdictions where it operates.

Target Customers and Users

Nabla serves a broad audience within the healthcare sector. Its users include individual physicians and practitioners as well as larger healthcare organizations such as clinics, medical groups, and health systems. The product appeals to primary care providers, specialists, nurse practitioners, therapists, and other clinicians who bear a heavy documentation load.

The company offers its technology in a way that can serve both individual clinicians looking to reduce their personal documentation burden and enterprise customers seeking to deploy the tool across many providers within an organization. For larger deployments, Nabla provides the infrastructure, integrations, and support needed to roll out the assistant at scale.

Company Growth and Position

Nabla has grown into a notable player in the ambient AI documentation space, a field that has attracted considerable attention and investment as healthcare organizations look for ways to combat clinician burnout and improve efficiency. The company has raised venture funding to support its development and expansion, and it has built partnerships and gained adoption among healthcare providers.

The company operates internationally, with roots in France and expanded operations in the United States, reflecting the global nature of the challenges it addresses and the demand for its type of technology across different healthcare systems. Its bilingual and multilingual capabilities support this cross-border operation.

Mission and Value Proposition

At its core, Nabla's value proposition is about restoring time and attention to the clinical encounter. By automating the documentation process, the company aims to reduce the hours clinicians spend on notes, lower the risk of burnout, and enable providers to be more present with their patients. The intended result is a better experience for both the clinician and the patient, along with more complete and consistent documentation.

The company frames its work around the idea that technology should support human clinicians rather than replace them, positioning its AI as a tool that amplifies the capacity of healthcare professionals. In doing so, Nabla contributes to the broader movement within health technology toward reducing administrative friction and improving the sustainability of clinical work.

Summary

Nabla is a France-based health technology company specializing in ambient artificial intelligence for clinical documentation. Its main product, Nabla Copilot, listens to patient-clinician conversations and automatically generates structured medical notes, integrating with electronic health record systems and supporting multiple languages and specialties. By focusing on reducing the documentation burden that contributes to clinician burnout, Nabla seeks to give providers more time for patient care while maintaining human oversight of all clinical documentation. The company operates across Europe and the United States and is part of the rapidly expanding market for AI-driven medical scribe and ambient clinical intelligence solutions.